Clinical Trials Directory

Trials / Unknown

UnknownNCT05594550

Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry. The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.

Conditions

Interventions

TypeNameDescription
OTHERData collectionDemographic data: Age, Sex, weight, height, main history and treatments. \- Biological data: CRP, PCT, albumin, pre-albumin
OTHERanalysis of thoracic scansmuscle area calculated on the T7 and T12 thoracic slices

Timeline

Start date
2022-10-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2022-10-26
Last updated
2022-10-26

Source: ClinicalTrials.gov record NCT05594550. Inclusion in this directory is not an endorsement.

Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS- (NCT05594550) · Clinical Trials Directory